Table 1 Characteristics of participants across weight change categories at the baseline and at the last follow up: Tehran Lipid and Glucose Study (TLGS)
Covariates | Weight change categories | Total | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lost > 5% | Lost 3–5% | Stable (± 3%) | Gained 3–5% | Gained > 5% | |||||||||
(n = 113 ) | (n = 26 ) | (n = 157 ) | (n = 47 ) | (n = 144 ) | (n = 487 ) | ||||||||
Baseline | Follow-up | Baseline | Follow-up | Baseline | Follow-up | Baseline | Follow-up | Baseline | Follow-up | Baseline | Follow-up | ||
Continues variables, median(Q1,Q3) | |||||||||||||
Age(year), Median (IQR) | 56 (52, 62) | 71 (67, 76) | 55.50 (53.75, 62) | 70 (68, 74.25) | 56 (51, 61) | 70 (65, 75) | 57(50, 62) | 72.5(66.75, 77.25) | 53.50 (50, 59) | 68 (65, 73) | 55(51, 61) | 70 (66, 75) | |
BMI (kg/m2) | 29.35 (26.03,31.40) | 28.53 (25.01, 30.97) | 26.97 (25.83, 29.85) | 28.50 (25.73, 30.53) | 28.51 (25.88, 31.20) | 29.29 (26.63, 32.88) | 27.47(25.46, 31.16) | 29.38(26.12, 34.04) | 27.48 (24.45, 31.19) | 30.66 (27.12, 34.75) | 28.06 (25.43, 31.20) | 29.38(26.4, 32.49) | |
TG( mg/dl) | 172 (124,274.5) | 135(98.5, 168) | 180.5(100.5, 241.75) | 113.5(87.5, 153.65) | 156 (117, 229) | 124 (99.5, 153.79) | 177(125,244) | 135(117, 171) | 148.5(109.25,203.75) | 143(104.6, 171) | 160(117, 234) | 134.31(101, 164.14) | |
TC (mg/dl) | 249 (204, 277) | 194.58 (177, 218.5) | 238.5 (231.25, 260) | Â | 237(210,272) | 193.59(175,213) | 242(222, 269) | 186(172, 211) | 231.5(207, 259.75) | 195.17(170.25, 216) | 238(209, 269) | 193.02(172, 214) | |
HDL (mg/dl) | 43 (35, 53) | 51 (46, 60) | 46 (35, 53) | 54.5 (35, 53) | 46 (39, 53) | 51.25 (44.76, 58) | 42(39, 49) | 49 (45, 54) | 46(35, 53) | 54.5(47.85, 57.88) | 46(39, 53) | 51(44.52, 57.05) | |
LDL (mg/dl) | 159 (125, 187) | 117 (95, 137) | 160.6 (125.8, 189) | 107.8 (97, 124,41) | 155.80 (127.80, 185.50) | 114.74 (95.6, 136) | 160.6(125.8, 189) | 107.8 (97, 124.41) | 160.6 (125.8, 189) | 107.8(97, 124.41) | 153.6(128, 181.8) | 113.85(92.8, 135.4) | |
FBS (mg/dl) | 99(89.5, 118.5) | 103(90.5, 136.38) | 92(88,110.75) | 104(91.75, 126.04) | 93 (87, 107.5) | 98 (89, 119) | 94(88, 103) | 97(88,109) | 92(86, 101.75) | 97(90,114.75) | 94(87, 107) | 98(90, 119) | |
Parity (number) | 5 (3, 6) | - | 4(3, 6) | - | 5 (3, 6) | - | 4 (3, 7) | - | 4 (3, 6) | - | 5 (3, 6) | - | |
Categorical variables, number (%) | |||||||||||||
Menopausal age | Normal | 71 (62.4) | - | 23 (88.5) | - | 98 (62.4) | - | 33 (70.2) | - | 80 (55.6) | - | 305(62.6) | - |
Early | 19 (16.8) | - | 1 (3.8) | - | 26 (16.6) | - | 4 (8.5) | - | 25 (17.4) | - | 75(15.4) | - | |
early Surgical | 23 (20.4) | - | 2 (7.7) | - | 33 (21) | - | 10 (21.3) | - | 39 (27.1) | - | 107(22) | - | |
Smoking status (Yes) | 10 (8.8) | 8 (8.6) | 0 (0) | 1 (5) | 8 (5.1) | 6 (4.8) | 4 (8.5) | 3 (7.9) | 8 (5.6) | 4 (3.2) | 30 (6.2) | 22 (5.5) | |
Physical activity (appropriate) number (%) | 43 (38.1) | 34 (30.1) | 7 (26.9) | 9 (34.6) | 41 (26.1) | 43 (27.4) | 17 (36.2) | 7 (14.9) | 46 (31.9) | 36 (25) | 154(31.6) | 129 (26.5) | |
History of family premature CVD (Yes) | 12 (10.6) | - | 5 (19.2) | - | 19 (12.1) | - | 10 (21.3) | - | 30 (20.8) | - | 76(15.6) | - | |
Incident of HTN (Yes) | - | 58 (51.3) | - | 14 (53.8) | - | 115 (73.2) | - | 37 (78.7) | - | 95 (66) | - | 319(65.5) | |
Survival time HTN | - | 13 (9, 15) | - | 12.5 (9, 16) | - | 9 (5, 15) | - | 9 (4, 15) | - | 12 (7, 16) | - | 11 (6,15) | |